M
Maurizio Benucci
Researcher at Society of Hospital Medicine
Publications - 220
Citations - 4540
Maurizio Benucci is an academic researcher from Society of Hospital Medicine. The author has contributed to research in topics: Rheumatoid arthritis & Etanercept. The author has an hindex of 34, co-authored 197 publications receiving 3672 citations. Previous affiliations of Maurizio Benucci include University of Udine.
Papers
More filters
Journal ArticleDOI
Sjögren's syndrome disease damage index and disease activity index: Scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients
Claudio Vitali,Gianluigi Palombi,Chiara Baldini,Maurizio Benucci,Stefano Bombardieri,Michele Covelli,Nicoletta Del Papa,Salvatore De Vita,Oscar Massimiliano Epis,Franco Franceschini,Roberto Gerli,Marcello Govoni,Susanna Maddali Bongi,Wanda Maglione,Sergio Migliaresi,Carlomaurizio Montecucco,Maddalena Orefice,Roberta Priori,Antonio Tavoni,Guido Valesini +19 more
TL;DR: The SSDDI is an adequate instrument to objectively measure damage in patients with SS, and that the SSDAI is a valid tool to measure disease activity when used either as a single-state index or as a transition index.
Journal ArticleDOI
Chronic widespread pain in the spectrum of rheumatological diseases
Fabiola Atzeni,M. Cazzola,Maurizio Benucci,Manuela Di Franco,Fausto Salaffi,Piercarlo Sarzi-Puttini +5 more
TL;DR: It is important for health professionals to be aware of this syndrome and to diagnose the patients to avoid a steady increase in diagnostic tests, and evidence points to central sensitization as an important neurophysiological aberration in the development of FMS.
Journal ArticleDOI
Long-term efficacy of infliximab in refractory posterior uveitis of Behçet's disease: a 24-month follow-up study
Laura Niccoli,Carlotta Nannini,Maurizio Benucci,Daniela Chindamo,Emanuele Cassarà,Carlo Salvarani,Luca Cimino,G Gini,I Lenzetti,Fabrizio Cantini +9 more
TL;DR: Infliximab is rapidly effective and safe in a high proportion BD patients with refractory posterior uveitis, and may be helpful to prevent recurrences.
Journal ArticleDOI
QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases
Filippo Bartalesi,Sonia Vicidomini,Delia Goletti,Costanza Fiorelli,Ginevra Fiori,Daniela Melchiorre,Enrico Tortoli,Antonia Mantella,Maurizio Benucci,Enrico Girardi,M. Matucci Cerinic,Alessandro Bartoloni +11 more
TL;DR: A strategy of simultaneous tuberculin skin and QuantiFERON-TB Gold in-tube testing in a low prevalence bacillus Calmette–Guérin vaccinated population, should maximise potentials of latent tuberculosis diagnosis.
Journal ArticleDOI
Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.
Maria Infantino,Valentina Grossi,Barbara Lari,Riccardo Bambi,Alessandro Perri,Matteo Manneschi,Giovanni Terenzi,Irene Liotti,Giovanni Ciotta,Cristina Taddei,Maurizio Benucci,Patrizia Casprini,Francesca Veneziani,Sergio Fabbri,Adolfo Pompetti,Mariangela Manfredi +15 more
TL;DR: iFlash1800 CLIA analyzer has shown highly accurate results for the anti‐SARS‐CoV‐2 antibodies profile and can be considered an excellent tool for COVID‐19 diagnostics.